127 related articles for article (PubMed ID: 9565044)
21. Scanning laser ophthalmoscope fundus perimetry after surgery for choroidal neovascularization.
Loewenstein A; Sunness JS; Bressler NM; Marsh MJ; de Juan E
Am J Ophthalmol; 1998 May; 125(5):657-65. PubMed ID: 9625549
[TBL] [Abstract][Full Text] [Related]
22. Intravitreal triamcinolone for choroidal neovascularization in ocular histoplasmosis syndrome.
Rechtman E; Allen VD; Danis RP; Pratt LM; Harris A; Speicher MA
Am J Ophthalmol; 2003 Oct; 136(4):739-41. PubMed ID: 14516819
[TBL] [Abstract][Full Text] [Related]
23. Presumed ocular histoplasmosis syndrome.
Johnston RL; Mitchell PC; Berman AM
J Am Optom Assoc; 1988 May; 59(5):401-5. PubMed ID: 2456321
[TBL] [Abstract][Full Text] [Related]
24. Choroidal neovascularization secondary to Candida albicans chorioretinitis.
Jampol LM; Sung J; Walker JD; Folk JC; Townsend-Pico WA; Lowder CY; Dodds EM; Westrich D; Terry J
Am J Ophthalmol; 1996 Jun; 121(6):643-9. PubMed ID: 8644807
[TBL] [Abstract][Full Text] [Related]
25. Laser photocoagulation for neovascular lesions nasal to the fovea. Results from clinical trials for lesions secondary to ocular histoplasmosis or idiopathic causes. Macular Photocoagulation Study Group.
Arch Ophthalmol; 1995 Jan; 113(1):56-61. PubMed ID: 7529993
[TBL] [Abstract][Full Text] [Related]
26. Subretinal surgery for choroidal neovascularization in patients with high myopia.
Uemura A; Thomas MA
Arch Ophthalmol; 2000 Mar; 118(3):344-50. PubMed ID: 10721956
[TBL] [Abstract][Full Text] [Related]
27. Proton-beam irradiation of subfoveal choroidal neovascular membranes in presumed ocular histoplasmosis syndrome: a case report.
Liem SE; Armbruster FC
J Am Optom Assoc; 1998 Aug; 69(8):493-9. PubMed ID: 9747044
[TBL] [Abstract][Full Text] [Related]
28. Choroidal neovascularization with granulomatous inflammation in ocular histoplasmosis syndrome.
Mann ES; Fogarty SJ; Kincaid MC
Am J Ophthalmol; 2000 Aug; 130(2):247-50. PubMed ID: 11004309
[TBL] [Abstract][Full Text] [Related]
29. Intravitreal bevacizumab as initial treatment for choroidal neovascularization associated with presumed ocular histoplasmosis syndrome.
Adán A; Navarro M; Casaroli-Marano RP; Ortiz S; Molina JJ
Graefes Arch Clin Exp Ophthalmol; 2007 Dec; 245(12):1873-5. PubMed ID: 17786466
[TBL] [Abstract][Full Text] [Related]
30. Argon green vs krypton red laser photocoagulation for extrafoveal choroidal neovascularization. One-year results in ocular histoplasmosis. The Canadian Ophthalmology Study Group.
Arch Ophthalmol; 1994 Sep; 112(9):1166-73. PubMed ID: 7522003
[TBL] [Abstract][Full Text] [Related]
31. Choroidal neovascularization after laser in situ keratomileusis in a patient with presumed ocular histoplasmosis syndrome.
Fedorovich I; Mehr DS; Oz O; Akduman L
Eur J Ophthalmol; 2004; 14(3):261-3. PubMed ID: 15206653
[TBL] [Abstract][Full Text] [Related]
32. Risk of visual impairment attributable to ocular histoplasmosis. Washington County Follow-up Eye Study Group.
Hawkins BS; Ganley JP
Arch Ophthalmol; 1994 May; 112(5):655-66. PubMed ID: 8185524
[TBL] [Abstract][Full Text] [Related]
33. Follow-up study in eyes with choroidal neovascularization caused by presumed ocular histoplasmosis.
Klein ML; Fine SL; Knox DL; Patz A
Am J Ophthalmol; 1977 Jun; 83(6):830-5. PubMed ID: 868984
[TBL] [Abstract][Full Text] [Related]
34. Biomicroscopic and histopathologic considerations regarding the feasibility of surgical excision of subfoveal neovascular membranes.
Gass JD
Am J Ophthalmol; 1994 Sep; 118(3):285-98. PubMed ID: 7521987
[TBL] [Abstract][Full Text] [Related]
35. Surgical removal vs observation for subfoveal choroidal neovascularization, either associated with the ocular histoplasmosis syndrome or idiopathic: II. Quality-of-life findings from a randomized clinical trial: SST Group H Trial: SST Report No. 10.
Hawkins BS; Miskala PH; Bass EB; Bressler NM; Childs AL; Mangione CM; Marsh MJ;
Arch Ophthalmol; 2004 Nov; 122(11):1616-28. PubMed ID: 15534122
[TBL] [Abstract][Full Text] [Related]
36. De novo lesions in presumed ocular histoplasmosis-like syndrome.
Miller SA; Stevens TS; de Venecia G
Br J Ophthalmol; 1976 Oct; 60(10):700-12. PubMed ID: 1009042
[TBL] [Abstract][Full Text] [Related]
37. Ultrastructural features of surgically excised subretinal neovascular membranes in the ocular histoplasmosis syndrome.
Saxe SJ; Grossniklaus HE; Lopez PF; Lambert HM; Sternberg P; L'Hernault N
Arch Ophthalmol; 1993 Jan; 111(1):88-95. PubMed ID: 8424731
[TBL] [Abstract][Full Text] [Related]
38. Fungal retinochoroiditis: a case report.
Wiedemann P; Heimann K
Eur J Ophthalmol; 1991; 1(1):55. PubMed ID: 1821199
[No Abstract] [Full Text] [Related]
39. New and classic insights into presumed ocular histoplasmosis syndrome and its treatment.
Oliver A; Ciulla TA; Comer GM
Curr Opin Ophthalmol; 2005 Jun; 16(3):160-5. PubMed ID: 15870572
[TBL] [Abstract][Full Text] [Related]
40. Responsiveness of the National Eye Institute Visual Function Questionnaire to changes in visual acuity: findings in patients with subfoveal choroidal neovascularization--SST Report No. 1.
Miskala PH; Hawkins BS; Mangione CM; Bass EB; Bressler NM; Dong LM; Marsh MJ; McCaffrey LD;
Arch Ophthalmol; 2003 Apr; 121(4):531-9. PubMed ID: 12695250
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
